DUBLIN--(BUSINESS WIRE)--The "Vascular Guidewires - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Vascular Guidewires market was estimated at $1,117 million in 2016 and is expected to reach $1,951 million by 2023 growing at a CAGR of 8.2%.
Rising incidences of cardiac disorders, demand for minimally invasive procedures, technological advancements and growth in geriatric population are some of the key factors propelling the market. However, risks & complications associated with Guidewires is hampering the market. Similarly, rise in the use of nitinol in vascular guidewires are expected to provide several opportunities for the market growth.
By product, coronary guidewires segment is anticipated to remain dominant throughout the forecast period owing to rise in prevalence of cardiac disorders globally.
Geographically, North America dominated the market owing to adoption of technologically advanced interventional vascular devices, unhealthy diet habits, favorable reimbursement rates for interventional procedures. In addition, presence of highly developed healthcare infrastructure provides opportunities for vascular guidewires market in the region.
Key Topics Covered
1. Executive Summary
3. Market Trend Analysis
4. Porters Five Force Analysis
5. Global Vascular Guidewires Market, By Product
6. Global Vascular Guidewires Market, By Coating Type
7. Global Vascular Guidewires Market, By End-User
8. Global Vascular Guidewires Market, By Geography
9. Key Developments
10. Company Profiling
- Abbott Vascular
- Cordis Corporation
- Braun Melsungen
- Boston Scientific
- CR Bard
- Asahi Intecc
- Gore Medical
- JOTEC GmbH
- Terumo Corporation
- Optimed Medizinische Instrumente GmbH
- Merit Medical Systems
- BrosMed Medical
- Lepu Medical Technology
For more information about this report visit https://www.researchandmarkets.com/research/mg8j7v/global_1_95?w=4